AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31832721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 30840024 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline hsCRP levels
Number of subjects: 4257
Study 30840024 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher longitudinal hsCRP levels
Number of subjects: 4257
Study 29044000 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenqi Fuzheng Injection combined with Cefoxitin Sodium
Number of subjects: 126
Study 29044000 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin Sodium
Number of subjects: 126
Study 26512456 — intervention group
Group type: EXPERIMENTAL
Intervention: Free 25-hydroxyvitamin D (25[OH]D) levels measured directly by ELISA
Number of subjects: 80
Study 26512456 — intervention group
Group type: EXPERIMENTAL
Intervention: Total serum 25(OH)D concentrations
Number of subjects: 80
Study 26512456 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated serum free 25(OH)D levels
Number of subjects: 80
Study 26512456 — intervention group
Group type: COMPARATOR
Intervention: Serum albumin and vitamin D binding protein (VDBP) levels
Number of subjects: 80
Study 23798006 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen suppression therapy (AST) for 6 months
Number of subjects: 108
Study 23798006 — intervention group
Group type: EXPERIMENTAL
Intervention: No/minimal comorbidity
Number of subjects: 108
Study 23798006 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/severe comorbidity
Number of subjects: 108
Study 23798006 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA velocity greater than the median
Number of subjects: 108
Study 23798006 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA velocity at or below the median
Number of subjects: 108
Study 22772617 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1%
Number of subjects: 209
Study 22772617 — intervention group
Group type: COMPARATOR
Intervention: Conventional gel formulation of adapalene 0.1% and clindamycin 1%
Number of subjects: 209
Study 19740402 — intervention group
Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 74
Study 19740402 — intervention group
Group type: EXPERIMENTAL
Intervention: BX471 at therapeutic doses
Number of subjects: 74
Study 19740402 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression-based QT correction methods
Number of subjects: 74
Study 17289823 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention and hypnosis
Number of subjects: 241
Study 17289823 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 241
Study 17289823 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 241
Study 15372178 — intervention group
Group type: EXPERIMENTAL
Intervention: Biken two-component (23.4 mg PT; 23.4 mg FHA) Pa vaccine (0.5 ml)
Number of subjects: 518
Study 11386626 — intervention group
Group type: EXPERIMENTAL
Intervention: General public's QOL ratings after considering life domains
Number of subjects: 0
Study 11386626 — intervention group
Group type: COMPARATOR
Intervention: General public's QOL ratings before considering life domains
Number of subjects: 0
Study 9648703 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm MSG
Number of subjects: 12
Study 9648703 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 gm MSG
Number of subjects: 12
Study 9648703 — intervention group
Group type: COMPARATOR
Intervention: 5 gm lactose (placebo)
Number of subjects: 12
Study 1561891 — intervention group
Group type: EXPERIMENTAL
Intervention: General neurotic syndrome
Number of subjects: 0
Study 3986084 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride (50 mg or 100 mg)
Number of subjects: 12
Study 3986084 — intervention group
Group type: EXPERIMENTAL
Intervention: Binodaline hydrochloride (50 mg or 100 mg)
Number of subjects: 12
Study 3986084 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 12
Study 30803706 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (maximum dose, 50mg/d) for 24 weeks
Number of subjects: 61
Study 30803706 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 61
Study 29808469 — intervention group
Group type: EXPERIMENTAL
Intervention: MD1003 (300 mg/day)
Number of subjects: 93
Study 29808469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 29808469 — intervention group
Group type: EXPERIMENTAL
Intervention: MD1003
Number of subjects: 93
Study 27895352 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intra-abdominal pressure (10 mmHg)
Number of subjects: 160
Study 27895352 — intervention group
Group type: COMPARATOR
Intervention: Standard intra-abdominal pressure (above 10 mmHg)
Number of subjects: 160
Study 25140597 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement with ω6:ω3 ratio of 8:1 and arginine
Number of subjects: 26
Study 25140597 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement with high ω9:ω6 ratio of 3.2:1 and low ω6:ω3 ratio of 1.4:1 and arginine
Number of subjects: 26
Study 25140597 — intervention group
Group type: COMPARATOR
Intervention: Skim milk, 0% fat
Number of subjects: 26
Study 25140597 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 26
Study 23055131 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian grocery store-based breast cancer education program
Number of subjects: 1540
Study 23055131 — intervention group
Group type: COMPARATOR
Intervention: Prostate cancer program
Number of subjects: 1540
Study 19306038 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg/day)
Number of subjects: 20
Study 19306038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17724802 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg/d
Number of subjects: 320
Study 17724802 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg/d
Number of subjects: 320
Study 17724802 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg/d
Number of subjects: 320
Study 17724802 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 20 mg/d
Number of subjects: 320
Study 15241905 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse (Listerine Antiseptic)
Number of subjects: 19
Study 15241905 — intervention group
Group type: COMPARATOR
Intervention: Negative control rinse
Number of subjects: 19
Study 11740701 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (15 mg/kg/day in 2 divided doses for 7 days)
Number of subjects: 87
Study 11740701 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin (10 mg/kg/day in 1 dose for 3 days)
Number of subjects: 87
Study 9420339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 807
Study 9420339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 807
Study 7798635 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB-exposed skin sensitization with hapten
Number of subjects: 0
Study 7798635 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal skin sensitization with hapten
Number of subjects: 0
Study 2192379 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-dried Urtica dioica
Number of subjects: 98
Study 2192379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 221691 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-deoxy-D-glucose
Number of subjects: 36
Study 221691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 31278446 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular tenodesis (IA) using an anchor suture for rotator cuff repair and LHBT tenodesis
Number of subjects: 60
Study 31278446 — intervention group
Group type: COMPARATOR
Intervention: Open subpectoral tenodesis (SP) using an interference screw after arthroscopic repair of the rotator cuff
Number of subjects: 60
Study 27997198 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPDOX
Number of subjects: 25
Study 27997198 — intervention group
Group type: COMPARATOR
Intervention: DEBDOX
Number of subjects: 25
Study 25876892 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaundice-reducing group (biliary drainage)
Number of subjects: 105
Study 25876892 — intervention group
Group type: COMPARATOR
Intervention: Non-reducing group (no biliary drainage)
Number of subjects: 105
Study 25876892 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaundice-reducing group
Number of subjects: 105
Study 25876892 — intervention group
Group type: COMPARATOR
Intervention: Non-reducing group
Number of subjects: 105
Study 23579517 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-pressure pneumoperitoneum (12 to 14 mmHg)
Number of subjects: 68
Study 23579517 — intervention group
Group type: COMPARATOR
Intervention: Low-pressure pneumoperitoneum (6 to 8 mmHg)
Number of subjects: 68
Study 21741519 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 60
Study 21741519 — intervention group
Group type: COMPARATOR
Intervention: Clamp-and-tie
Number of subjects: 60
Study 19259717 — intervention group
Group type: EXPERIMENTAL
Intervention: ANN-guided CPAP titration
Number of subjects: 115
Study 19259717 — intervention group
Group type: COMPARATOR
Intervention: Conventional CPAP titration
Number of subjects: 115
Study 19259717 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 115
Study 16707149 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium, high-vitamin C and -carotene diet
Number of subjects: 550
Study 15229100 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (500 mcg twice a day)
Number of subjects: 41
Study 15229100 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone (30 mg/day)
Number of subjects: 41
Study 15229100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 15229100 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone (500 mcg twice a day for an additional 8 weeks)
Number of subjects: 41
Study 11395591 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (25 mg bolus followed by 20 mg/hr continuous infusion for 24 hrs)
Number of subjects: 60
Study 11395591 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone (300 mg bolus)
Number of subjects: 60
Study 11395591 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (300 mg bolus followed by 45 mg/hr for 24 hrs)
Number of subjects: 60
Study 11395591 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60
Study 9244941 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.8‐1 mg/kg for induction; 4‐6 mg/kg/h for maintenance)
Number of subjects: 48
Study 9244941 — intervention group
Group type: COMPARATOR
Intervention: Etomidate (0.25 mg/kg for induction) and isoflurane (0.6‐0.8% for maintenance)
Number of subjects: 48
Study 9244941 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 48
Study 9244941 — intervention group
Group type: COMPARATOR
Intervention: Etomidate and isoflurane
Number of subjects: 48
Study 8299077 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate/5-fluorouracil (5-FU) followed by leucovorin rescue (MFL)
Number of subjects: 70
Study 8299077 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil/leucovorin (FLV)
Number of subjects: 70
Study 8299077 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 70
Study 2567893 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid (TA group)
Number of subjects: 12
Study 2567893 — intervention group
Group type: COMPARATOR
Intervention: placebo (control group)
Number of subjects: 12
Study 30285594 — intervention group
Group type: EXPERIMENTAL
Intervention: Live-animal training
Number of subjects: 38
Study 30285594 — intervention group
Group type: COMPARATOR
Intervention: Online video instruction
Number of subjects: 38
Study 28468030 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi practitioners
Number of subjects: 34
Study 28468030 — intervention group
Group type: COMPARATOR
Intervention: Sedentary individuals
Number of subjects: 34
Study 26293443 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP at a dose of 150mg/day for 3 days, subsequently increased to 300mg/day
Number of subjects: 0
Study 26293443 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum of 4mg every 1-2 hourly for initial 6 weeks, then every 2-4 hourly for next 6 weeks
Number of subjects: 0
Study 26293443 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI)
Number of subjects: 0
Study 26293443 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI) + BUP
Number of subjects: 0
Study 26293443 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI) + Nicotine Replacement Therapy (NRT)
Number of subjects: 0
Study 26293443 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP + NRT + BI
Number of subjects: 0
Study 23834653 — intervention group
Group type: EXPERIMENTAL
Intervention: Sivelestat (0.2 mg/kg/h continuous intravenous infusion)
Number of subjects: 30
Study 23834653 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 30
Study 21810633 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based early intervention with 5 or 6 home visits from a specially trained research nurse
Number of subjects: 667
Study 21810633 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based early intervention
Number of subjects: 667
Study 19041336 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 12
Study 19041336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16960287 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (hemoglobin 7.0 g/dL maintained between 7.0 and 9.0 g/dL)
Number of subjects: 67
Study 16960287 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy (hemoglobin 10.0 g/dL maintained between 10.0 and 12.0 g/dL)
Number of subjects: 67
Study 16960287 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 67
Study 16960287 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 67
Study 15663681 — intervention group
Group type: COMPARATOR
Intervention: Orchiectomy alone (O)
Number of subjects: 100
Study 15663681 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy plus flutamide (OF)
Number of subjects: 100
Study 11583604 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9240801 — intervention group
Group type: COMPARATOR
Intervention: Routine verbal and written instructions
Number of subjects: 627
Study 9240801 — intervention group
Group type: COMPARATOR
Intervention: Reminder phone call
Number of subjects: 627
Study 9240801 — intervention group
Group type: COMPARATOR
Intervention: Transportation tokens and toy on return
Number of subjects: 627
Study 9240801 — intervention group
Group type: COMPARATOR
Intervention: Withholding of school forms until time of reading
Number of subjects: 627
Study 9240801 — intervention group
Group type: COMPARATOR
Intervention: Parents taught to read induration with nurse home visit
Number of subjects: 627
Study 8106653 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (10 to 50 mg/day)
Number of subjects: 433
Study 3539709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous branched chain amino acids in 20% dextrose (group A)
Number of subjects: 59
Study 3539709 — intervention group
Group type: COMPARATOR
Intervention: Oral lactulose (group B)
Number of subjects: 59
Study 3539709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous branched chain amino acids (preliminary uncontrolled study)
Number of subjects: 59
Study 29614696 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic deep brain stimulation at various frequencies (40-160 Hz, 40 Hz intervals)
Number of subjects: 20
Study 29614696 — intervention group
Group type: COMPARATOR
Intervention: Higher frequencies (>80 Hz)
Number of subjects: 20
Study 29614696 — intervention group
Group type: COMPARATOR
Intervention: Lower frequencies (40 Hz)
Number of subjects: 20
Study 30641005 — intervention group
Group type: EXPERIMENTAL
Intervention: Chang'an Recipe I (CR I)
Number of subjects: 58
Study 30641005 — intervention group
Group type: COMPARATOR
Intervention: CR I placebo
Number of subjects: 58
Study 24439531 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise class emphasizing health outcomes
Number of subjects: 0
Study 24439531 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise class emphasizing appearance outcomes
Number of subjects: 0
Study 22561549 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrabrief-pulse ECT (0.3 ms)
Number of subjects: 25
Study 22561549 — intervention group
Group type: COMPARATOR
Intervention: Brief-pulse ECT (1 ms)
Number of subjects: 25
Study 22126534 — intervention group
Group type: COMPARATOR
Intervention: Traditional lumbar exercise
Number of subjects: 4325
Study 22126534 — intervention group
Group type: COMPARATOR
Intervention: Core stabilization exercise
Number of subjects: 4325
Study 22126534 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional lumbar exercise with psychosocial education
Number of subjects: 4325
Study 22126534 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization with psychosocial education
Number of subjects: 4325
Study 18633000 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Care Activity Desk (HCAD) training
Number of subjects: 81
Study 18633000 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 81
Study 16100705 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (12 weeks)
Number of subjects: 83
Study 14587302 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose triple therapy (omeprazole, amoxicillin, clarithromycin) for 1 week
Number of subjects: 225
Study 14587302 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose triple therapy (omeprazole, amoxicillin, clarithromycin) for 1 week
Number of subjects: 225
Study 14587302 — intervention group
Group type: COMPARATOR
Intervention: Failed eradication therapy
Number of subjects: 225
Study 10740541 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose regimen)
Number of subjects: 57
Study 10740541 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 57
Study 9082107 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsuction drainage
Number of subjects: 80
Study 9082107 — intervention group
Group type: COMPARATOR
Intervention: High-vacuum drainage
Number of subjects: 80
Study 1387351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sufentanil (150 micrograms)
Number of subjects: 20
Study 1387351 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (150 micrograms)
Number of subjects: 20
Study 6572128 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.76% sodium monofluorophosphate dentifrice
Number of subjects: 751
Study 6572128 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% sodium fluoride mouthrinse
Number of subjects: 751
Study 6572128 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of dentifrice and mouthrinse
Number of subjects: 751
Study 31208125 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual six‐month‐long physical exercise program (group I)
Number of subjects: 0
Study 31208125 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physical activity program (group II)
Number of subjects: 0
Study 31208125 — intervention group
Group type: COMPARATOR
Intervention: Control group (group III)
Number of subjects: 0
Study 27870557 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress task
Number of subjects: 39
Study 27870557 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking images
Number of subjects: 39
Study 27870557 — intervention group
Group type: COMPARATOR
Intervention: Neutral images
Number of subjects: 39
Study 27870557 — intervention group
Group type: COMPARATOR
Intervention: Motivational control images
Number of subjects: 39
Study 27870557 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cue task completed first
Number of subjects: 39
Study 27870557 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress task completed first
Number of subjects: 39
Study 25034950 — intervention group
Group type: EXPERIMENTAL
Intervention: High saturated fat meal
Number of subjects: 58
Study 25034950 — intervention group
Group type: COMPARATOR
Intervention: High oleic sunflower oil meal
Number of subjects: 58
Study 25034950 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with prior MDD and more stressors
Number of subjects: 58
Study 24378144 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 154
Study 24378144 — intervention group
Group type: COMPARATOR
Intervention: Usual approach (control group)
Number of subjects: 154
Study 22840231 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 35
Study 22840231 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 35
Study 19651344 — intervention group
Group type: EXPERIMENTAL
Intervention: Damon 3 self-ligating bracket
Number of subjects: 66
Study 19651344 — intervention group
Group type: COMPARATOR
Intervention: Tru Straight conventional twin bracket
Number of subjects: 66
Study 19651344 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics taken
Number of subjects: 66
Study 19651344 — intervention group
Group type: COMPARATOR
Intervention: No analgesics taken
Number of subjects: 66
Study 17804348 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention for promoting antiretroviral therapy adherence
Number of subjects: 9
Study 14987268 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 treatments of psoralen‐UVA (PUVA) therapy
Number of subjects: 8
Study 14987268 — intervention group
Group type: COMPARATOR
Intervention: 12 treatments of psoralen‐UVA (PUVA) therapy
Number of subjects: 8
Study 11475855 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test (modified Bruce protocol)
Number of subjects: 53
Study 9551739 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules plus canola oil and margarine (omega‐3 group)
Number of subjects: 39
Study 9551739 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil capsules plus sunflower oil and margarine (omega‐6 group)
Number of subjects: 39
Study 7998418 — intervention group
Group type: EXPERIMENTAL
Intervention: TGP-943 vaccine
Number of subjects: 2137
Study 3045202 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/day) for 8 weeks
Number of subjects: 23